Biomimetic Virus-Like Particles as Severe Acute Respiratory Syndrome Coronavirus 2 Diagnostic Tools

10.1038/s41586-020-2196-x

10.3201/eid2606.200299

10.7326/M20-3012

10.1001/jama.2020.8598

10.1080/14737159.2020.1757437

Coronavirus (COVID-19) Update: FDA Authorizes First Diagnostic Test Using At-Home Collection of Saliva Specimens; https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-using-home-collection-saliva (accessed 2020-07-16).

10.1021/acscentsci.0c00501

Which U.S. States Meet WHO Recommended Testing Criteria? https://coronavirus.jhu.edu/testing/testing-positivity (accessed 2020-07-13).

Testing Data in the U.S.; https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/testing-in-us.html (accessed 2020-08-08).

10.1038/d41586-020-02053-6

Comparison of National RT-PCR Primers, Probes, and Protocols for SARS-CoV-2 Diagnostics; Johns Hopkins Center for Health Security.

10.1038/s41564-020-0761-6

10.2807/1560-7917.ES.2020.25.6.2000082

CDC Assays for SARS-CoV-2 Detection; https://www.idtdna.com/pages/landing/coronavirus-research-reagents/cdc-assays (accessed 2020-07-15).

Thermo Fisher Scientific Launches New AcroMetrix Coronavirus 2019 (COVID-19) RNA Control (RUO) to Monitor and Validate COVID-19 Molecular Diagnostic Tests; https://www.biospace.com/article/releases/thermo-fisher-scientific-launches-new-acrometrix-coronavirus-2019-covid-19-rna-control-ruo-/ (accessed 2020-07-15).

10.1007/s10561-016-9600-7

10.4137/BMI.S6094

DNA/RNA ShieldTM; https://files.zymoresearch.com/protocols/_r1100-50_r1100-250_r1200-25_r1100-125_dna_rna_shield.pdf (accessed 2020-07-16).

10.1038/ejhg.2013.145

10.1016/j.addr.2020.06.024

10.1016/j.jviromet.2015.04.002

10.1038/srep23803

10.1007/s12560-019-09400-5

Asuragen Develops Armored RNA Quant® SARS-CoV-2 Control; https://www.biospace.com/article/releases/asuragen-develops-armored-rna-quant-sars-cov-2-control/ (accessed 2020-07-15).

AccuPlexTM SARS-CoV-2 Reference Material Kit; https://www.seracare.com/AccuPlex-SARSCoV2-Reference-Material-Kit-0505-0126/ (accessed 2020-07-15).

Swann H., 2020, bioRxiv

Hsiao P., 2005, Mol. Ther., S978

10.1038/s41565-020-0737-y

10.3390/vaccines8010139

10.1039/C8RA02084A

AccuPlex. Virus Materials | SeraCare; https://www.seracare.com/resources-and-education/accuplex-recombinant-virus-materials/ (accessed 2020-07-15).

10.1016/S0969-2126(96)00060-3

10.1166/jnn.2005.507

10.1016/j.jviromet.2015.08.023

10.1002/wnan.1587

10.1016/j.tim.2011.03.006

10.1007/s12052-011-0365-y

10.1039/C5CS00287G

10.3389/fpls.2019.00803

10.1021/bi00427a011

10.1002/ange.201005243

10.1093/nar/gkw1154

10.1021/acs.bioconjchem.9b00731

10.1128/JVI.79.6.3277-3288.2005

10.1128/JVI.01044-14

10.1371/journal.pone.0181844

10.1080/14686996.2018.1517587

10.1002/adfm.201908743

10.3390/ijms21103544

10.1186/s40168-017-0317-z

10.1186/s12864-018-5152-5

10.1073/pnas.1707102114

10.1166/jnn.2005.507

10.1128/JVI.06566-11

10.1021/nn502043d

10.1016/j.jconrel.2019.06.019

10.1021/bm300590x

10.1101/gr.6.10.995

PCR - QIAGEN; https://www.qiagen.com/fi/service-and-support/learning-hub/molecular-biology-methods/pcr/ (accessed 2020-07-25).

10.1021/acsinfecdis.0c00464

10.1093/nar/gkp045

10.1111/j.1365-2672.2012.05384.x

10.1373/clinchem.2013.211045

10.1021/acs.analchem.6b03746

10.1016/S0969-2126(01)00135-6

10.1016/S0022-2836(02)00135-3

10.1093/protein/gzq069

10.1016/j.virol.2015.03.008

10.1017/S1355838200991441

10.1080/03639040802192806

Bancroft J. B., 1970, Advances in Virus Research, 99

10.1016/j.virol.2004.12.009